Trial Profile
DPP4 inhibitor (Vildagliptin) and its effect on Glucose levels and Arterial stiffness in patients with Type II Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Nov 2016 New trial record
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension